Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29488 | 152 | 22.3 | 34% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BRANCH SHEMYAKIN BIOORGAN CHEM | Address | 1 | 50% | 1% | 1 |
2 | HEMATOGENEOUS METASTASIS | Author keyword | 1 | 50% | 1% | 1 |
3 | PANC02 | Author keyword | 0 | 33% | 1% | 1 |
4 | RAT LUNG TUMORS | Author keyword | 0 | 33% | 1% | 1 |
5 | SAHLGRENS HOSP RADIAT PHYS | Address | 0 | 33% | 1% | 1 |
6 | BLOOD VESSEL PERMEABILITY | Author keyword | 0 | 17% | 1% | 1 |
7 | HUMAN TONGUE SQUAMOUS CELL CARCINOMA | Author keyword | 0 | 13% | 1% | 1 |
8 | RAT TUMORS | Author keyword | 0 | 13% | 1% | 1 |
9 | GENOMIC SUBTRACTION | Author keyword | 0 | 10% | 1% | 1 |
10 | METASTATIC INEFFICIENCY | Author keyword | 0 | 10% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BRAIN DISPOSITION | 1 | 50% | 1% | 1 |
2 | ANIMAL EXPERIMENTAL MODEL | 0 | 33% | 1% | 1 |
3 | ONCOGENIC VIRUSES | 0 | 17% | 1% | 1 |
4 | AGKISTRODON HALYS HALYS | 0 | 100% | 1% | 1 |
5 | PROTHROMBIN CONVERTING ENZYME | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CURRENT STATUS OF ANTIFIBRINOLYTIC DRUGS | 1989 | 15 | 6 | 17% |
THE AORTO-ENDOTHELIAL CELL, CULTIVATED INVITRO, IN THE RESEARCH OF AGENTS - CELL-PHYSIOLOGIC CHARACTERIZATION AND APPLYING POSSIBILITIES OF THE CELL-LINE BKEZ-7 | 1984 | 27 | 38 | 21% |
No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer | 2000 | 30 | 126 | 7% |
The Pharmacokinetic/Pharmacodynamic Pipeline: Translating Anticancer Drug Pharmacology to the Clinic | 2011 | 14 | 60 | 2% |
PREOPERATIVE CHEMOTHERAPY - ADVANTAGES AND CLINICAL-APPLICATION IN STAGE III BREAST-CANCER | 1985 | 2 | 19 | 5% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BRANCH SHEMYAKIN BIOORGAN CHEM | 1 | 50% | 0.7% | 1 |
2 | SAHLGRENS HOSP RADIAT PHYS | 0 | 33% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000169773 | TETRATHIOMOLYBDATE//ATN 224//ANGIOTROPIN CURNP RIBOKINE |
2 | 0.0000100463 | LIVER SPLEEN SCAN//GASTROENTEROL HEPATOLSECT HEPATOL//IMAN KHOMEINI HOSP COMPLEX |
3 | 0.0000092664 | ANGIOGENESIS PROCESS//GRP DIGITAL SIGNAL PROC//AUTOMAT CONTROL INFORMAT TECHNOL |
4 | 0.0000083203 | BONE ENHANCER//BIOSURG RD//E9903 |
5 | 0.0000073109 | DING PROTEIN//DING PROTEINS//HUMAN PHOSPHATE BINDING PROTEIN |
6 | 0.0000072562 | CARDIOTOXIC EFFECT//FOOD AGR SCI MICROBIOL CELL SCI//HYDRAZINOALCOHOL |
7 | 0.0000057709 | HEMATOPOYESIS LEUCEMIA//HEMATOPOIESIS LEUKAEMIA//LEUKAEMIA MODEL |
8 | 0.0000053433 | UROKINASE RECEPTOR//UPAR//UPA |
9 | 0.0000051386 | LECT2//CHONDROMODULIN I//SHARK CARTILAGE |
10 | 0.0000047832 | LIPID PORES//LCMR//AXON VOLUME |